Standard Biotools Inc (LAB) — Financial Flexibility Index
Standard Biotools Inc (LAB) has a Financial Flexibility Index of -0.59x as of March 2026. Free cash flow of $-46.03 Million (operating CF $-46.60 Million minus capex $570.00K) represents -1% of total liabilities ($77.99 Million). Also explore LAB net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Standard Biotools Inc Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Standard Biotools Inc across 20 annual periods. Check strategic asset allocation of Standard Biotools Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Standard Biotools Inc (2006–2025)
Year-by-year free cash flow to debt coverage for Standard Biotools Inc. For the full company profile including market capitalisation, see LAB market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.46x | $-66.05 Million | $-74.35 Million | $143.46 Million | ▲ +52.1% |
| 2024 | -0.96x | $-135.10 Million | $-143.45 Million | $140.62 Million | ▼ -1018.8% |
| 2023 | -0.09x | $-40.46 Million | $-43.29 Million | $471.12 Million | ▲ +52.6% |
| 2022 | -0.18x | $-85.55 Million | $-89.37 Million | $471.78 Million | ▼ -6.3% |
| 2021 | -0.17x | $-30.80 Million | $-44.06 Million | $180.62 Million | ▼ -1072.8% |
| 2020 | -0.01x | $-2.70 Million | $-15.42 Million | $185.71 Million | ▲ +95.1% |
| 2019 | -0.29x | $-32.68 Million | $-35.21 Million | $111.20 Million | ▼ -174.0% |
| 2018 | -0.11x | $-24.83 Million | $-25.20 Million | $231.53 Million | ▼ -22.3% |
| 2017 | -0.09x | $-22.48 Million | $-24.10 Million | $256.42 Million | ▲ +34.8% |
| 2016 | -0.13x | $-34.03 Million | $-39.10 Million | $253.16 Million | ▼ -43.2% |
| 2015 | -0.09x | $-24.04 Million | $-34.70 Million | $256.16 Million | ▼ -58.6% |
| 2014 | -0.06x | $-15.22 Million | $-22.62 Million | $257.14 Million | ▼ -137.9% |
| 2013 | 0.16x | $3.10 Million | $-1.59 Million | $19.80 Million | ▲ +113.5% |
| 2012 | -1.15x | $-15.09 Million | $-17.48 Million | $13.07 Million | ▼ -63.2% |
| 2011 | -0.71x | $-15.87 Million | $-17.54 Million | $22.43 Million | ▼ -1418.3% |
| 2010 | -0.05x | $-9.97 Million | $-11.51 Million | $213.97 Million | ▲ +48.8% |
| 2009 | -0.09x | $-18.71 Million | $-19.51 Million | $205.77 Million | ▲ +37.6% |
| 2008 | -0.15x | $-27.81 Million | $-28.72 Million | $190.69 Million | ▼ -29.9% |
| 2007 | -0.11x | $-20.79 Million | $-21.76 Million | $185.11 Million | ▲ +17.3% |
| 2006 | -0.14x | $-19.37 Million | $-22.31 Million | $142.66 Million | — |